Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Andreas Burchert

Andreas Burchert

MD, PhD
Philipps-University Marburg

Academic history

Andreas Burchert, MD, PhD, is the Deputy Clinical Director and a Senior Physician at the Philipps-University Marburg, Marburg, Germany.

Speaking on novel therapies for AML

Prof. Burchert’s primary research focus is on novel therapies for the treatment of acute myeloid leukemia (AML). In particular, Prof. Burchert has recently worked on a study investigating whether FLT3-ITD inhibition with sorafenib can prevent AML relapse.

Andreas Burchert

Filter Results ▼
Loading... Loading results...

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals